WHAT IS LATISSE®?

LATISSE® is a prescription treatment used to grow eyelashes and highly recommended by Dr. Christine to increase lash length and thickness. LATISSE® is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes. User studies showed a 106% increase in lash fullness, a 25% increase in length and an 18% increase in darkness.

LATISSE® IS USED FOR:

  • Transforming short, thin lashes into long, darker, lush lashes
  • Increasing the number of lashes you have
  • Is the only FDA approved prescription treatment used to grow eyelashes

HOW DOES LATISSE® WORK?

Eyelashes don’t grow all at once, they grow in phases. LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways:

  1. It increases the length of the growth phase.
  2. It increases the number of hairs in the growth phase, yielding longer, thicker lashes. By week 16, you will have LONG, THICK, DARK lashes that everyone will notice.

HOW DO I APPLY LATISSE®?

LATISSE® solution is a once-a-day treatment you apply yourself each evening to the base of the upper eyelashes.

WHAT HAPPENS IF I STOP USING LATISSE®?

If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.

COULD LATISSE® CAUSE THE COLOR OF MY EYES TO CHANGE?

Patients with brown pigmentation (even in small amounts) have the potential for increased brown iris pigmentation. In the clinical study for LATISSE®, iris pigmentation was NOT reported (applied once per day, outside of the eye, along the lash line).

It is however, important to note that during the study where the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure/glaucoma, there was reported increased brown iris pigmentation; which is likely to be permanent. Therefore, as long as you follow the guidelines for use, you should experience similar outcomes seen in the clinical trials.